About 8 results found for searched term "Vancomycin" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M4862 | Vancomycin HCl | Antibiotic |
| Vancocin HCl | ||
| Vancomycin HCl is a hydrochloride of vancomycin that is a narrow-spectrum glycopeptide antibacterial agent. | ||
| M9334 | Vancomycin | Animal Modeling |
| Vancomycin is a glycopeptide antibiotic as well as a macrocyclic compound that can be used to construct models of bronchiectasis combined with lung infections, as well as for studies related to various bacterial infectious conditions. | ||
| M6129 | Dalfopristin | Antibiotic |
| RP54476 | ||
| Dalfopristin is a semi-synthetic antibiotic. , Quinupristin/Dalfopristin (Q/D) is a valuable alternative antibiotic Vancomycin, with multidrug resistance of Enterococcus faecium infection research. | ||
| M6131 | Pristinamycin | Anti-infection |
| The pristinamycins exhibit a strong synergistic antibacterial activity against a wide range of Gram-positive and some Gram-negative bacteria, including methicillin- and vancomycin-resistant strains. | ||
| M24753 | Suvratoxumab | Anti-infection |
| MEDI4893 | ||
| Suvratoxumab (MEDI4893) is a long-acting, high-affinity humanized anti-α-toxin monoclonal antibody (IgG1κ type). Suvratoxumab potently neutralizes α-toxin, a key S. aureus virulence factor. Suvratoxumab improves survival and reduces lung injury in an immunocompromised mice model of pneumonia. Suvratoxumab also enhances the antibacterial activity of Vancomycin or Linezolid . | ||
| M29688 | Ceftobiprole medocaril sodium | Antibiotic |
| BAL5788 sodium | ||
| Ceftobiprole medocaril (BAL5788) sodium is the parenteral proagent of Ceftobiprole. Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. | ||
| M30013 | Ceftobiprole medocaril | Antibiotic |
| BAL5788 | ||
| Ceftobiprole medocaril (BAL5788) is the parenteral proagent of Ceftobiprole. Ceftobiprole is a parenteral pyrrolidinone cephalosporin. Ceftobiprole is a broad-spectrum cephalosporin with high levels of in vitro activity against methicillin- (MRSA) and vancomycin-resistant staphylococci (VRSA) and penicillin-resistant streptococci. Ceftobiprole also inhibits gram-positive and gram-negative pathogens. | ||
| M40503 | Lugdunin | Anti-infection |
| Lugdunin is a class of non-ribosomal peptides (NRPs) with good antimicrobial activity and inhibits methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and Listeria monocytogenes. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
